Thyroid hormone level is associated with the frequency and severity of Guillain–Barré syndrome

References

• van den Berg B, Walgaard C, Drenthen J, et al. Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat RevNeurol 2014;10(8):469–82.
   Google Scholar
• McGrogan A, Madle GC, Seaman HE, de Vries CS. The epidemiology of Guillain-Barre syndrome worldwide. A systematic literature review. Neuroepidemiology 2009;32(2):150–63.
   PubMed Web of Science ®Google Scholar
• Auso E, Lavado-Autric R, Cuevas E, et al. A moderate and transient deficiency of maternal thyroid function at the beginning of fetal neocorticogenesis alters neuronal migration. Endocrinology 2004;145(9):4037–47.
   PubMed Web of Science ®Google Scholar
• Zoeller RT, Rovet J. Timing of thyroid hormone action in the developing brain: clinical observations and experimental findings. J Neuroendocrinol 2004;16(10):809–18.
   PubMed Web of Science ®Google Scholar
• Zhang M, Ma Z, Qin H, Yao Z. Thyroid hormone potentially benefits multiple sclerosis via facilitating remyelination. Mol Neurobiol 2016; 53(7):4406–16.
   Web of Science ®Google Scholar
• Long Y, Zheng Y, Chen M, et al. Serum thyroid-stimulating hormone and anti-thyroglobulin antibody are independently associated with lesions in spinal cord in central nervous system demyelinating diseases. PLoS One 2014;9(8):e100672.
   PubMed Web of Science ®Google Scholar
• Zhao W, Zeng H, Zhang X, et al. A high thyroid stimulating hormone level is associated with diabetic peripheral neuropathy in type 2 diabetes patients. Diabetes Res Clin Pract 2016; 115:122–9.
   Web of Science ®Google Scholar
• Umehara T, Matsuno H, Toyoda C, Oka H. Thyroid hormone level is associated with motor symptoms in de novo Parkinson's disease. J Neurol 2015;262(7):1762–8.
   PubMed Web of Science ®Google Scholar
• Johansson P, Almqvist EG, Johansson JO, et al. Reduced cerebrospinal fluid level of thyroxine in patients with Alzheimer's disease. Psychoneuroendocrinology 2013;38(7):1058–66.
   PubMed Web of Science ®Google Scholar
• Chachamovitz DS, Vigario PD, Silva SO, et al. Does low-normal serum TSH level adversely impact cognition in elderly adults and might methimazole therapy improve outcomes? Endocr J 2016; 63(5):495–505.
   PubMed Web of Science ®Google Scholar
• Polizzi A, Ruggieri M, Vecchio I, et al. Autoimmune thyroiditis and acquired demyelinating polyradiculoneuropathy. Clin Neurol Neurosurg 2001;103(3):151–4.
   PubMed Web of Science ®Google Scholar
• Van der Meche FG, Van Doorn PA, Meulstee J, Jennekens FG. Diagnostic and classification criteria for the Guillain-Barre syndrome. Eur Neurol 2001;45(3):133–9.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu J. Hyponatremia is a predictor for poor outcome in Guillain-Barre syndrome. Neurol Res 2015;37(4):347–51.
   PubMed Web of Science ®Google Scholar
• Hughes RA, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial prednisolone in acute polyneuropathy. Lancet (London, England) 1978;2(8093):750–3.
   PubMed Web of Science ®Google Scholar
• Bauer M, Glenn T, Pilhatsch M, et al. Gender differences in thyroid system function: relevance to bipolar disorder and its treatment. Bipolar Disord 2014;16(1):58–71.
   PubMed Web of Science ®Google Scholar
• Ghabaee M, Jabedari B, Al EEN, et al. Serum and cerebrospinal fluid antioxidant activity and lipid peroxidation in Guillain-Barre syndrome and multiple sclerosis patients. Int J Neurosci 2010;120(4):301–4.
   PubMed Web of Science ®Google Scholar
• Smith KJ, Kapoor R, Felts PA. Demyelination: the role of reactive oxygen and nitrogen species. Brain Pathol 1999;9(1):69–92.
   PubMed Web of Science ®Google Scholar
• Ahmed OM, Ahmed RG, El-Gareib AW, et al. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: II-the developmental pattern of neurons in relation to oxidative stress and antioxidant defense system. Int J Dev Neurosci 2012;30(6):517–37.
   PubMed Web of Science ®Google Scholar
• Messarah M, Boumendjel A, Chouabia A, et al. Influence of thyroid dysfunction on liver lipid peroxidation and antioxidant status in experimental rats. Exp Toxicol Pathol 2010;62(3):301–10.
   PubMed Web of Science ®Google Scholar
• Santi A, Duarte MM, de Menezes CC, Loro VL. Association of lipids with oxidative stress biomarkers in subclinical hypothyroidism. Int J Endocrinol 2012;2012:856359.
   PubMed Web of Science ®Google Scholar
• Metwalley KA, Farghaly HS, Saad K, Othman HA. Oxidative status in children and adolescents with autoimmune thyroiditis. Clin Exp Med 2016; 16(4):571–5.
   PubMed Web of Science ®Google Scholar
• Ahmed OM, Abd El-Tawab SM, Ahmed RG. Effects of experimentally induced maternal hypothyroidism and hyperthyroidism on the development of rat offspring: I. The development of the thyroid hormones-neurotransmitters and adenosinergic system interactions. Int J Dev Neurosci 2010;28(6):437–54.
   PubMed Web of Science ®Google Scholar
• Mancini A, Di Segni C, Raimondo S, et al. Thyroid hormones, oxidative stress, and inflammation. Mediators Inflamm 2016;2016:6757154.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Yang Y, Zhang B, et al. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica. Neuro Endocrinol Lett 2009;30(1):85–90.
   PubMed Web of Science ®Google Scholar
• Li Q, Qi X, Jia W. 3,3',5-triiodothyroxine inhibits apoptosis and oxidative stress by the PKM2/PKM1 ratio during oxygen-glucose deprivation/reperfusion AC16 and HCM-a cells: T3 inhibits apoptosis and oxidative stress by PKM2/PKM1 ratio. Biochem Biophys Res Commun 2016;475(1):51–6.
   PubMed Web of Science ®Google Scholar
• Zhang M, Zhan XL, Ma ZY, et al. Thyroid hormone alleviates demyelination induced by cuprizone through its role in remyelination during the remission period. Exp Biol Med 2015;240(9):1183–96.
   PubMed Web of Science ®Google Scholar